GAMMA Investing LLC Invests $70,000 in Spyre Therapeutics, Inc. (NASDAQ:SYRE)
GAMMA Investing LLC purchased a new position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 4,356 shares of the company’s stock, valued at approximately $70,000. Several other institutional investors have also modified their holdings of the stock. FMR LLC raised its holdings in shares […]
